Big Pharma markets left on a ‘patent cliff’-hanger
FT News Briefing
00:00
Navigating the Patent System and Its Implications for Big Pharma
This chapter explores the intricate dynamics between the pharmaceutical industry and government regulations on intellectual property, with a special focus on patents. It highlights the financial implications of patent expirations for major drugs like Keytruda and discusses the challenges ahead for companies like Merck as they face a significant loss in revenue.
Transcript
Play full episode
